You are now leaving www.WINLEVI-HCP.com

INDICATION AND IMPORTANT SAFETY INFORMATION

View All

WINLEVI® RESOURCES

HCP The ONLY WAY to TOPICALLY target androgen receptors in acne vulgaris1-3*

*The exact mechanism of WINLEVI in acne vulgaris is unknown.1

WINLEVI® (clascoterone cream 1%) Tube and Packaging

Access and Reimbursement Support

For your convenience, please download the Authorization and Appeals Kit, as well as individual sample letters you may need for patient access to WINLEVI.
HCP
Formulary Exception Request Letter
HCP
HCP
Prior Authorization Request Letter
HCP
HCP
Letter of Appeal
HCP
HCP
Letter of Medical Necessity
HCP

discover savings

Pass savings along to your patients with the WINLEVI Co-Pay Program

  • Commercially insured patients may pay as little as $20 when WINLEVI is covered or a prior authorization (PA) is approved*
  • Commercially insured patients may pay as little as $90 when WINLEVI is not covered or a PA is denied
  • The WINLEVI Co-Pay Program can be used at any participating pharmacy
DISCOVER THE PROGRAM

*Enrollment is subject to applicable program maximum restrictions, terms and conditions, and eligibility criteria.

WINLEVI® (clascoterone cream 1%) Co-Pay Card